drugset
drugset / Trial / NCT01638910

Efficacy and Safety of a Combined Oral Contraceptive of Estradiol Valerate and Dienogest in Healthy Female Subjects

NCT01638910 ↗

Phase 3 Completed 955 enrolled Bayer
NaSingle-groupOpen-labelPrevention

Summary

To evaluate the efficacy and safety of a combined oral contraceptive of estradiol valerate and dienogest in healthy female subjects.

Timeline

Start
2012-06
Primary completion
2014-11
Completion
2014-11

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dienogest Small molecule 2 mg Oral
Subject Dienogest Small molecule 3 mg Oral
Subject estradiol valerate Unknown 1 mg Oral
Subject estradiol valerate Unknown 2 mg Oral
Subject estradiol valerate Unknown 3 mg Oral

Indications

No indication recorded.